Global Astaxanthin Market 2024-2028

Description

List of Tables

The astaxanthin market is forecasted to grow by USD 484.12 mn during 2023-2028, accelerating at a CAGR of 9.82% during the forecast period. The report on the astaxanthin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing health and wellness awareness, rising demand for natural ingredients, and rise of e-commerce and online shopping.

Technavio's astaxanthin market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	8.91%
CAGR	9.82%
Incremental Value	$484.12mn

By Source

Natural
Synthetic

By Type

Dry
Liquid

By Geographical Landscape

North America
Europe
APAC
South America
Middle East and Africa

This study identifies the increasing natural and sustainable sourcing of astaxanthin as one of the prime reasons driving the astaxanthin market growth during the next few years. Also, rising advertising and marketing campaigns and use of astaxanthin in beauty and cosmetic products will lead to sizable demand in the market.

The report on the astaxanthin market covers the following areas:

Astaxanthin market sizing
Astaxanthin market forecast
Astaxanthin market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading astaxanthin market vendors that include Algamo s.r.o., Algatech Ltd., AstaMAZ NZ Ltd., Atacama Bio Natural Products S.A., BASF SE, Beijing Gingko Group, Biogenic Co. Ltd., Cardax Inc., Cyanotech Corp., Divis Laboratories Ltd., EID Parry India Ltd., ENEOS Holdings Inc., FENCHEM, Fuji Chemical Industries Co. Ltd., Koninklijke DSM NV, NOW Health Group Inc., Otsuka Pharmaceutical Co. Ltd., Piveg Inc., Valensa International, and Zhejiang NHU Company Ltd.. Also, the astaxanthin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR76549

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

4.1 Global astaxanthin market 2018 - 2022
4.2 Source Segment Analysis 2018 - 2022
4.3 Type Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition

6 Market Segmentation by Source

6.1 Market segments
6.2 Comparison by Source
6.3 Natural - Market size and forecast 2023-2028
6.4 Synthetic - Market size and forecast 2023-2028
6.5 Market opportunity by Source

7 Market Segmentation by Type

7.1 Market segments
7.2 Comparison by Type
7.3 Dry - Market size and forecast 2023-2028
7.4 Liquid - Market size and forecast 2023-2028
7.5 Market opportunity by Type

8 Customer Landscape

8.1 Customer landscape overview

9 Geographic Landscape

9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 APAC - Market size and forecast 2023-2028
9.6 South America - Market size and forecast 2023-2028
9.7 Middle East and Africa - Market size and forecast 2023-2028
9.8 US - Market size and forecast 2023-2028
9.9 China - Market size and forecast 2023-2028
9.10 Germany - Market size and forecast 2023-2028
9.11 France - Market size and forecast 2023-2028
9.12 Japan - Market size and forecast 2023-2028
9.13 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks

12 Vendor Analysis

12.1 Vendors covered
12.2 Market positioning of vendors
12.3 BASF SE
12.4 Beijing Gingko Group
12.5 Cardax Inc.
12.6 Cyanotech Corp.
12.7 Divis Laboratories Ltd.
12.8 EID Parry India Ltd.
12.9 ENEOS Holdings Inc.
12.10 FENCHEM
12.11 Fuji Chemical Industries Co. Ltd
12.12 Koninklijke DSM NV
12.13 NOW Health Group Inc.
12.14 Otsuka Pharmaceutical Co. Ltd.
12.15 PIVEG Inc.
12.16 Valensa International
12.17 Zhejiang NHU Company Ltd.

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations